Reference
Yu AF, et al. Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy. JACC: CardioOncology 2: 166-175, No. 2, Jun 2020. Available from: URL: http://doi.org/10.1016/j.jaccao.2020.03.002
Rights and permissions
About this article
Cite this article
Trastuzumab. Reactions Weekly 1813, 221 (2020). https://doi.org/10.1007/s40278-020-80978-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80978-9